Key facts
- Notable investors include LYFE Capital, Hyfinity Investments.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Huihan Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Huihan Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huihan Technology
Developer of advanced biomedical materials designed to enhance clinical outcomes in surgical care and tissue regeneration. The company offers integrated platforms including colloidal silver, hydrogel, bacterial cellulose, bio-3D, and MT technologies, enabling healthcare professionals to reduce postoperative complications and accelerate patient recovery.
- Sector
- Healthcare
- HQ
- Changshu, China
- Founded
- 2005
- Website
- hvha.cn/
- Ownership
- Privately Held (backing)
Huihan Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huihan Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huihan Technology in its N-PORT filings yet. We sweep new filings monthly.